
    
      This is a randomized, double blind, placebo control, multi-centre clinical study in
      hyperlipidemia patients.

      Enrolled subjects will be randomized to the treatment group or control group, and receive
      Probucol or placebo continuously for 8 weeks; Treatment group: Imported Probucol 250 mg (1
      tablet) bid. p.o Control group: Placebo 1 tablet bid. p.o
    
  